Glycorex Transplantation
2,13
SEK
+0,47 %
Mindre end 1K følgere
GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+0,47%
-22,26%
+4,41%
+18,01%
+53,24%
+126,6%
-66,19%
-79,71%
-79,02%
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Læs mereMarkedsværdi
167,96 mio. SEK
Aktieomsætning
15,45 t SEK
Omsætning
35,16 mio.
EBIT %
-29,69 %
P/E
-
Udbytteafkast, %
-
Finanskalender
23.5
2025
Delårsrapport Q1'25
27.5
2025
Generalforsamling '25
29.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Glycorex Transplantation AB: First ABO-incompatible transplantation in Portugal with Glycosorb® ABO
Glycorex Transplantation AB (GTAB B): First blood group-incompatible pediatric heart transplantation in Austria using Glycosorb® ABO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools